Track market-moving stories before they get noisy

Wall Street analysts expect Newmont Corporation (NEM - Free Report) to post quarterly earnings of $2.13 per share in its upcoming report, which indicates a year-over-year increase of 49%. Revenues are expected to be $6.19 billion, up 16.4% from the year-ago quarter.

The current level reflects a downward revision of 3% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.

Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.

While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.

Bearing this in mind, let's now explore the average estimates of specific Newmont metrics that are commonly monitored and projected by Wall Street analysts.

Analysts predict that the 'Geographic Revenue- Nevada Gold Mines' will reach $862.82 million. The estimate indicates a change of +10.2% from the prior-year quarter.

The average prediction of analysts places 'Geographic Revenue- Pe?asquito' at $964.15 million. The estimate points to a change of +18.3% from the year-ago quarter.

According to the collective judgment of analysts, 'Geographic Revenue- Merian' should come in at $342.45 million. The estimate points to a change of +53.6% from the year-ago quarter.

Analysts expect 'Geographic Revenue- Cerro Negro' to come in at $211.49 million. The estimate points to a change of +88.8% from the year-ago quarter.

The combined assessment of analysts suggests that 'Average Realized Price - Silver' will likely reach 71 dollars per ounce. Compared to the present estimate, the company reported 30 dollars per ounce in the same quarter last year.

Analysts' assessment points toward 'Attributable Production - Total Gold' reaching 1231 thousands of ounces. The estimate is in contrast to the year-ago figure of 1478 thousands of ounces.

The collective assessment of analysts points to an estimated 'Average Realized Price - Gold' of 4774 dollars per ounce. Compared to the present estimate, the company reported 3320 dollars per ounce in the same quarter last year.

The consensus among analysts is that 'Average Realized Price - Copper' will reach N/A. The estimate is in contrast to the year-ago figure of N/A.

Based on the collective assessment of analysts, 'AISC Consolidated - Nevada Gold Mines' should arrive at 1746 dollars per ounce. The estimate is in contrast to the year-ago figure of 1771 dollars per ounce.

It is projected by analysts that the 'Attributable Production - Nevada Gold Mines' will reach 224 thousands of ounces. The estimate is in contrast to the year-ago figure of 239 thousands of ounces.

The consensus estimate for 'Attributable Production - Cerro Negro' stands at 45 thousands of ounces. Compared to the present estimate, the company reported 42 thousands of ounces in the same quarter last year.

Analysts forecast 'Attributable Production - Penasquito' to reach 44 thousands of ounces. Compared to the current estimate, the company reported 148 thousands of ounces in the same quarter of the previous year.

View all Key Company Metrics for Newmont here>>>

Over the past month, Newmont shares have recorded returns of -13.6% versus the Zacks S&P 500 composite's +0.6% change. Based on its Zacks Rank #3 (Hold), NEM will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Key Takeaways Dover is expected to report Q2 revenues of $2.21 billion and EPS of $2.72 before the July 23 release.DOV saw strong bookings, but weaker vehicle-services volumes may offset gains in the quarter.Dover expects strength across multiple segments, supported by demand, shipments and margin performance. Dover Corporation (DOV - Free Report) is set to release second-quarter 2026 results on July 23, 2026, before the opening bell.

The Zacks Consensus Estimate for DOV’s revenues is pegged at $2.21 billion, indicating a 7.9% rise from the year-ago reported figure.

The consensus estimate for earnings is pegged at $2.72 per share, which implies year-over-year growth of 11.5%. The estimate has been unchanged in the past 60 days.

Image Source: Zacks Investment Research

Dover’s Solid Earnings Surprise HistoryDOV’s earnings beat the Zacks Consensus Estimate in the trailing four quarters, as seen in the chart below. The company has an average earnings surprise of 2.1%.

Image Source: Zacks Investment Research

What the Zacks Model Unveils for DOV StockOur model does not predict an earnings beat for DOV this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. That is not the case here, as you can see below.

DOV’s Earnings ESP: Dover has an Earnings ESP of -0.01%. You can uncover the best stocks before they are reported with our Earnings ESP Filter.

Zacks Rank of Dover: DOV currently carries a Zacks Rank of 2.

Factors to Note Regarding Dover’s Q2 PerformanceDOV has been witnessing robust bookings across most of its segments on strong demand and shipment levels, which are likely to have supported its second-quarter performance. However, the impacts of lower volumes in vehicle services are expected to have negated these gains. 

Dover’s margins are likely to have benefited from an improved price-cost spread and tight cost controls for a while. However, the negative impacts of supply-chain constraints and input inflation have been acting as headwinds. These are likely to get reflected in DOV’s earnings results.

Q2 Segment Projections for DoverIn the Engineered Products segment, ongoing strong demand in aerospace and defense components is expected to have been offset by weak demand in the vehicle-service business. Our estimate for the segment’s revenues is pegged at $283.5 million, indicating a 2.7% increase from the prior-year quarter’s actual.

The estimate for the Engineered Products segment’s adjusted EBITDA is pegged at $63 million, indicating an 8.1% increase from the prior-year quarter’s actual.

The Clean Energy and Fueling Solutions segment is likely to have gained solid shipments and new orders in clean energy components, fluid transport and North America retail fueling. We expect the segment’s revenues to be $591 million, indicating growth of 8.2% from the year-earlier actual.

The estimate for the Clean Energy and Fueling Solutions segment’s adjusted EBITDA is pegged at $131.5 million, indicating a 12.7% increase from the year-ago quarter’s actual.

The Imaging and Identification segment's results are expected to reflect the benefits of growth in core marking and coding, and serialization software. Our prediction for the segment’s revenues is $307 million, indicating a 5.1% rise from the prior-year quarter’s actual.

We project the segment’s adjusted EBITDA to be $82 million, which indicates 1.3% growth from the second-quarter 2026 reported figure, aided by a solid margin performance.

Dover’s Pumps and Process Solutions segment’s results are likely to reflect growth in biopharma and platform cycles businesses. We anticipate the segment’s revenues to increase 7.2% year over year to $558 million. The consensus mark for the segment’s second-quarter adjusted EBITDA is pegged at $193 million, implying an 11.9% year-over-year rise.

In the Climate and Sustainability Technologies segment, results are expected to gain from shipment and order rates in refrigerated door cases and CO2 systems. We expect quarterly revenues to be $459 million, implying an 10.4% increase from the year-earlier reported figure. The estimate for the segment’s adjusted EBITDA is pegged at $102 million, whereas it reported $85 million in the second quarter of 2025.

DOV Stock’s Price PerformanceDover’s shares have gained 15.7% in the past year compared with the industry’s 6.8% growth.

Image Source: Zacks Investment Research

Stocks That Warrant a LookHere are some companies with the right combination of elements to post an earnings beat in their upcoming releases.

Hubbell Incorporated (HUBB - Free Report) , slated to release second-quarter 2026 results on July 28, has an Earnings ESP of +0.62% and a Zacks Rank of 2 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for Hubbell’s second-quarter 2026 earnings is pegged at $5.32 per share, suggesting a year-over-year rise of 7.9%. HUBB has a trailing four-quarter average surprise of 4.7%.

Deere & Company (DE - Free Report) , slated to release third-quarter fiscal 2026 results on Aug. 20, has an Earnings ESP of +6.74% and a Zacks Rank of 3 at present.

The Zacks Consensus Estimate for Deere’s third-quarter fiscal 2026 earnings is pegged at $4.82 per share, indicating a year-over-year rise of 1.5%. DE has a trailing four-quarter average surprise of 10.2%.

Illinois Tool Works Inc. (ITW - Free Report) , slated to release second-quarter 2026 results on July 28, has an Earnings ESP of +0.31% and a Zacks Rank of 3 at present.

The Zacks Consensus Estimate for Illinois Tool Works’ second-quarter 2026 earnings is pegged at $2.80 per share, implying a year-over-year rise of 8.5%. ITW has a trailing four-quarter average surprise of 2.8%.

In its upcoming report, T-Mobile (TMUS - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $2.52 per share, reflecting a decline of 11.3% compared to the same period last year. Revenues are forecasted to be $22.76 billion, representing a year-over-year increase of 7.7%.

Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 2.4% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.

Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.

While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.

In light of this perspective, let's dive into the average estimates of certain T-Mobile metrics that are commonly tracked and forecasted by Wall Street analysts.

Analysts expect 'Revenue- Total service revenues' to come in at $18.79 billion. The estimate indicates a year-over-year change of +7.7%.

Based on the collective assessment of analysts, 'Equipment revenues' should arrive at $3.56 billion. The estimate suggests a change of +3.5% year over year.

The consensus among analysts is that 'Revenue- Other revenues' will reach $255.06 million. The estimate points to a change of 0% from the year-ago quarter.

The average prediction of analysts places 'Revenue- Prepaid revenues' at $2.51 billion. The estimate indicates a change of -5.2% from the prior-year quarter.

It is projected by analysts that the 'Revenue- Postpaid revenues' will reach $15.86 billion. The estimate suggests a change of +12.7% year over year.

According to the collective judgment of analysts, 'Revenue- Wholesale and other service revenues' should come in at $658.49 million. The estimate indicates a year-over-year change of -8.2%.

Analysts forecast 'Total postpaid customer accounts' to reach 34.69 million. The estimate compares to the year-ago value of 31.50 million.

The collective assessment of analysts points to an estimated 'Net customer additions - Total postpaid customers - Postpaid phone customers' of 395.49 thousand. The estimate is in contrast to the year-ago figure of 830.00 thousand.

The combined assessment of analysts suggests that 'Postpaid ARPA' will likely reach $153.10 . The estimate compares to the year-ago value of $149.87 .

View all Key Company Metrics for T-Mobile here>>>

Over the past month, T-Mobile shares have recorded returns of +5.9% versus the Zacks S&P 500 composite's +0.6% change. Based on its Zacks Rank #3 (Hold), TMUS will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

The upcoming report from Dow Inc. (DOW - Free Report) is expected to reveal quarterly earnings of $1.20 per share, indicating an increase of 385.7% compared to the year-ago period. Analysts forecast revenues of $12.01 billion, representing an increase of 18.8% year over year.

The consensus EPS estimate for the quarter has undergone a downward revision of 10.5% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.

Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.

While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.

Given this perspective, it's time to examine the average forecasts of specific Dow Inc. metrics that are routinely monitored and predicted by Wall Street analysts.

The consensus among analysts is that 'Net Sales- Performance Materials & Coatings' will reach $2.16 billion. The estimate suggests a change of +1.4% year over year.

The average prediction of analysts places 'Revenues- Corporate' at $162.67 million. The estimate suggests a change of -0.8% year over year.

Analysts expect 'Net Sales- Packaging & Specialty Plastics' to come in at $6.66 billion. The estimate points to a change of +32.5% from the year-ago quarter.

The collective assessment of analysts points to an estimated 'Net Sales- Industrial Intermediates & Infrastructure' of $3.01 billion. The estimate suggests a change of +8% year over year.

Analysts predict that the 'Operating EBITDA- Packaging & Specialty Plastics' will reach $1.84 billion. Compared to the present estimate, the company reported $440.00 million in the same quarter last year.

The combined assessment of analysts suggests that 'Operating EBITDA- Performance Materials & Coatings' will likely reach $274.51 million. Compared to the current estimate, the company reported $344.00 million in the same quarter of the previous year.

View all Key Company Metrics for Dow Inc. here>>>

Over the past month, shares of Dow Inc. have returned -5.7% versus the Zacks S&P 500 composite's +0.6% change. Currently, DOW carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Investors interested in Utilities stocks should always be looking to find the best-performing companies in the group. NextEra Energy (NEE - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Utilities peers, we might be able to answer that question.

NextEra Energy is one of 111 companies in the Utilities group. The Utilities group currently sits at #14 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. NextEra Energy is currently sporting a Zacks Rank of #2 (Buy).

Over the past 90 days, the Zacks Consensus Estimate for NEE's full-year earnings has moved 0.2% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.

According to our latest data, NEE has moved about 10.6% on a year-to-date basis. Meanwhile, the Utilities sector has returned an average of 6.5% on a year-to-date basis. As we can see, NextEra Energy is performing better than its sector in the calendar year.

Another stock in the Utilities sector, NiSource (NI - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 10.1%.

The consensus estimate for NiSource's current year EPS has increased 0.2% over the past three months. The stock currently has a Zacks Rank #2 (Buy).

Breaking things down more, NextEra Energy is a member of the Utility - Electric Power industry, which includes 63 individual companies and currently sits at #155 in the Zacks Industry Rank. This group has gained an average of 7.7% so far this year, so NEE is performing better in this area. NiSource is also part of the same industry.

NextEra Energy and NiSource could continue their solid performance, so investors interested in Utilities stocks should continue to pay close attention to these stocks.

It wasn't that long ago that Oracle (ORCL 3.05%) was a top tech stock benefiting from the hype around artificial intelligence (AI). But that excitement has quickly turned to concern about elevated spending on AI, high debt levels, and perhaps too much dependence on OpenAI. The result: a stock that's now lost roughly half its value in the past 12 months.

Oracle, however, remains a big name in the tech sector, and it still has plenty of growth opportunities stemming from AI. With it now down over 60% from its highs, is now a good time to buy the stock?

Image source: Getty Images.

Oracle's big risk is that its investments won't pay off When Oracle reported its latest earnings numbers last month, the business showed strong growth on both its top and bottom lines. But the bigger issue for investors is what lies ahead for the business, and whether all the spending on AI will prove worth it, especially given that one of its key customers is OpenAI, whose future doesn't look all that solid these days as it struggles with profitability and growing competition.

For the fiscal year ending May 31, Oracle's capital expenditures totaled $55.7 billion, easily more than double what it spent a year ago -- $21.2 billion. It also reported long-term liabilities of $176.9 billion, up from $114.7 billion in the prior-year period. The company continues to invest heavily in AI cloud infrastructure, with it projecting to raise $40 billion for the current fiscal year, through a combination of debt and equity.

This aggressive spending on AI has been a concern in the tech sector lately, and it has weighed heavily on Oracle's stock, particularly after the company signed a $300 billion cloud deal with OpenAI last year.

Today's Change

(

-3.05

%) $

-3.86

Current Price

$

122.56

Is Oracle's stock cheap enough that it's worth the risk? There is a risk that Oracle's aggressive investments in AI simply won't pan out as expected. But if a stock is trading at a low enough price, it can sometimes be a calculated risk for investors. Right now, Oracle is trading at a forward price-to-earnings multiple below 16 (based on analyst expectations), which is far less than the S&P 500 average of 22. It's also trading around where it was three years ago.

For long-term investors, Oracle's stock could make for a compelling buying opportunity today. With so much bearishness priced in, it could be a good contrarian pick up given its reduced valuation. While there may be some short-term risk, this is still a top tech company that generates strong profit margins, which is why I wouldn't be surprised if it recovers in the long run.

HomeStock IdeasLong IdeasBasic Materials

SummaryFranco-Nevada Corporation stands out for its unrivaled asset diversification, superior margins, and capital discipline, making it the premier vehicle in the precious metals sector.Record gold/silver prices helped it deliver record revenue ($651M), operating cash flow ($520M), and exceptional ~92.9% cash margins, with new assets and higher metals prices driving robust YoY growth.Importantly, FNV's business model shields it from inflation and provides it with massive discovery optionality, never mind unrivaled cash flow diversification vs. producers.Trading at ~18.8x 2026 EV/OCF and in a rare low-risk Buy zone, I see this pullback below US$200.00 as a gift, with investors getting Cobre Panama optionality for free.Looking for a portfolio of ideas like this one? Members of Alluvial Gold Research get exclusive access to our subscriber-only portfolios. Learn More » erlucho/iStock via Getty Images

All figures are in United States Dollars unless otherwise noted. G/T = grams per tonne (of gold or silver). GEOs = gold-equivalent ounces. AISC refers to all-in sustaining costs. LOMP = life of mine plan. TPD = tonnes per day. UG = Underground. OP = open-pit. MTPA = million tonnes per annum. FS/DFS = Definitive Feasibility Study. PFS = Pre-feasibility study. PEA = Preliminary Economic Assessment. NSR = net smelter

32.56K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of FNV, FNV:CA either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Disclaimer: Taylor Dart is not a Registered Investment Advisor or Financial Planner. This writing is for informational purposes only. It does not constitute an offer to sell, a solicitation to buy, or a recommendation regarding any securities transaction. The information contained in this writing should not be construed as financial or investment advice on any subject matter. Taylor Dart expressly disclaims all liability in respect to actions taken based on any or all of the information on this writing. Given the volatility in the precious metals sector, position sizing is critical, so when buying small-cap precious metals stocks, position sizes should be limited to 6% or less of one's portfolio.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

SAN DIEGO, July 20, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating Hyliion Holdings Corp. (NYSE American: HYLN) on behalf of investors who suffered losses and whether those losses may be recoverable under federal securities laws.

What Should Hyliion Investors Do?
If you purchased Hyliion securities and suffered losses on your investment, you are encouraged to contact Johnson Fistel to learn more about the investigation.

To join the investigation click here.

For more information, contact Jim Baker at [email protected] or (619) 814-4471.

There is no cost or obligation to you.

Why Is Johnson Fistel Investigating Hyliion?
On June 23, 2026, Pelican Way Research published a short report concerning Hyliion titled “Hyliion: A Glorified Science Project Who Has Continuously Failed To Meet Expectations And Is Now Throwing Around A Meaningless Deal.” The report stated that Hyliion’s stock had risen significantly following the Company’s announcement of a non-binding LOI with VFG Holdings for up to 250 KARNO Cores, representing approximately $133 million in potential revenue.

Pelican Way Research alleged that the VFG LOI accounted for roughly one-third of Hyliion’s reported $400 million-plus pipeline and questioned whether the LOI provided meaningful commercial validation. The report further alleged that VFG, which Pelican Way identified as VFG Tech Holdings, LLC, was incorporated in January 2026, appeared to have only four LinkedIn employees, had a minimal website, and lacked evidence of funding or operating substance sufficient to support an order of that size.

In light of these allegations, Johnson Fistel is investigating whether Hyliion Holdings complied with federal securities laws. If you suffered losses, or are a long-term holder of Hyliion stock, contact Johnson Fistel.

About Johnson Fistel, PLLP | Securities Fraud & Investor Rights
Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder litigation involving securities fraud, breaches of fiduciary duties, and other violations of state and federal law.

Johnson Fistel has been recognized as one of the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services. In 2024, the firm recovered approximately $90,725,000 for investors.

Attorney advertising. Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices. This press release may be considered a promotional communication. The attorney responsible for this communication is Frank J. Johnson.

Contact:
Johnson Fistel, PLLP
501 W. Broadway, Suite 800
San Diego, CA 92101
James Baker, Investor Relations – or – Frank J. Johnson, Esq.
(619) 814-4471
[email protected] | [email protected]

Costco (COST - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Over the past month, shares of this warehouse club operator have returned -1.1%, compared to the Zacks S&P 500 composite's +0.6% change. During this period, the Zacks Retail - Discount Stores industry, which Costco falls in, has lost 0.9%. The key question now is: What could be the stock's future direction?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For the current quarter, Costco is expected to post earnings of $6.51 per share, indicating a change of +10.9% from the year-ago quarter. The Zacks Consensus Estimate has changed +0.2% over the last 30 days.

The consensus earnings estimate of $20.42 for the current fiscal year indicates a year-over-year change of +13.5%. This estimate has remained unchanged over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $22.5 indicates a change of +10.2% from what Costco is expected to report a year ago. Over the past month, the estimate has remained unchanged.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Costco is rated Zacks Rank #3 (Hold).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

In the case of Costco, the consensus sales estimate of $94.08 billion for the current quarter points to a year-over-year change of +9.2%. The $301.52 billion and $324.99 billion estimates for the current and next fiscal years indicate changes of +9.6% and +7.8%, respectively.

Last Reported Results and Surprise HistoryCostco reported revenues of $70.53 billion in the last reported quarter, representing a year-over-year change of +11.6%. EPS of $4.93 for the same period compares with $4.28 a year ago.

Compared to the Zacks Consensus Estimate of $69.5 billion, the reported revenues represent a surprise of +1.47%. The EPS surprise was +0.41%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates two times over this period.

ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Costco is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Costco. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.

NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP reminds purchasers of First Solar, Inc. (NASDAQ: FSLR) securities of a pending securities class action.

THE CASE: A class action seeks to recover damages for investors who purchased First Solar securities between February 26, 2025 and February 24, 2026.

YOUR OPTIONS: You may be entitled to compensation without payment of any out-of-pocket fees. See if you can recover losses or contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.

First Solar's stock fell $33.09 per share, or 13.61%, to close at $210.12 on February 25, 2026, after the Company disclosed Q4 and full-year 2025 results that missed expectations and issued lower-than-expected fiscal year 2026 revenue guidance. Investors have until August 24, 2026 to seek lead plaintiff status.

The Alleged Production Underutilization Acceleration

A solar module manufacturer cannot sustain margins when its international production facilities sit idle. The lawsuit contends that throughout the Class Period, First Solar deliberately curtailed Series 6 Plus module output at its Malaysia and Vietnam factories, initially characterizing the move as a temporary response to tariff uncertainty. As alleged, management framed this underutilization as preserving "optionality" while the tariff landscape evolved, without disclosing that these curtailments could persist well into fiscal year 2026 and drag down the Company's forward outlook.

The action claims that by the time British Petroleum affiliates defaulted on 6.6 gigawatts of bookings at a base average selling price of $0.294 per watt, the demand shortfall for international product had deepened substantially, yet management continued to describe the trade environment as "long term favorable."

Production Relocation Management and the South Carolina Facility

The complaint recounts that in late October 2025, management announced a new 3.7-gigawatt U.S. production facility, with South Carolina confirmed as the location in November 2025, to onshore Series 6 finishing operations, a program carrying approximately $260 million in capital expenditures and $70 million in non-capitalized relocation costs. As detailed in the action, management represented that this facility would "commence commercial operations in the second half of 2026" and improve gross margins by reducing tariff and logistics costs.

However, the lawsuit chronicles that management failed to disclose the extent to which this massive onshoring effort, combined with continued international facility underutilization, would compress near-term financial performance:

Alleged Production Impact by the Numbers

6.6 gigawatts of contracted bookings terminated after BP affiliate defaults, eliminating a major source of international facility demand$330 million total program direct spend committed to the South Carolina relocation, including equipment deinstallation, shipping, and reinstallation3.7 gigawatts of planned capacity at the new facility would not fully replace Malaysia and Vietnam output volumesApproximately 40% of underutilization costs at international facilities were non-cash, obscuring the full operational drag on reported resultsSeries 6 production curtailments that began as "temporary" in Q2 2025 were still unresolved when disappointing FY 2026 guidance was issued in February 2026 Calculate your potential recovery or call (212) 363-7500.

"The complaint raises serious questions about whether investors received accurate information regarding the operational costs and timeline risks of simultaneously idling international production and standing up a major new domestic facility," -- Joseph E. Levi, Esq.

Get more information about this case or contact Joseph E. Levi, Esq. at (212) 363-7500.

WHY LEVI & KORSINSKY — Ranked in ISS Securities Class Action Services' Top 50 Report for seven consecutive years, Levi & Korsinsky, LLP is a nationally recognized leader in shareholder rights litigation. With a team of over 70 professionals, the firm has recovered hundreds of millions of dollars for investors. Investors who suffered losses have until August 24, 2026 to seek appointment as lead plaintiff. Attorney Advertising. Prior results do not guarantee similar outcomes.

Frequently Asked Questions About the FSLR Lawsuit

Q: Who is eligible to join the FSLR investor lawsuit? A: Investors who purchased FSLR stock or securities between February 26, 2025 and February 24, 2026 and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses, not on whether you still hold the shares.

Q: What specific misstatements does the FSLR lawsuit allege? A: The complaint alleges First Solar made materially false or misleading statements regarding its capacity to manage U.S. tariff impacts, the extent of production underutilization at international facilities, and the likely negative effects of onshoring operations on projected fiscal year 2026 performance. When the true state was revealed, the stock price declined sharply.

Q: How much did FSLR stock drop? A: Shares fell approximately 13.61%, a decline of $33.09 per share, after the Company disclosed disappointing Q4 and full-year 2025 results and issued lower-than-expected FY 2026 revenue guidance. An earlier corrective disclosure on January 7, 2026 caused an additional 10.29% decline. Investors who purchased shares during the class period at artificially inflated prices may be entitled to compensation.

Q: What do FSLR investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [email protected] or (212) 363-7500. No immediate action is required to remain eligible as a class member.

Q: What if I already sold my FSLR shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold them. Investors who bought during the class period and sold at a loss may still participate.

Q: What does it cost me to participate? A: Nothing. Securities class actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.

Q: What if I missed the lead plaintiff deadline? A: The deadline applies only to investors seeking lead plaintiff appointment. Class members who miss it can still participate in any settlement or recovery.

Q: What court was the FSLR class action filed in? A: The case was filed in the United States District Court for the Eastern District of New York, governed by the Private Securities Litigation Reform Act of 1995.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Ed Korsinsky, Esq.

33 Whitehall Street, 27th Floor

New York, NY 10004

[email protected]

Tel: (212) 363-7500

Fax: (212) 363-7171

New York, New York--(Newsfile Corp. - July 20, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against First Solar, Inc. (NASDAQ: FSLR) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired First Solar securities between February 26, 2025 and February 24, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/FSLR.

First Solar Case Details

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, the Complaint alleges that:

Defendants had overstated First Solar's capacity to manage the impact of U.S. tariff policy on the Company's business Defendants understated the extent to which its responses to U.S. tariff policy, including the intentional underutilization of production facilities in Malaysia and Vietnam, and attempted relocation of production to the U.S., were likely to negatively impact First Solar's projected performance in the 2026 fiscal year; as a result, Defendants' public statements were materially false and misleading at all relevant times.What's Next for First Solar Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/FSLR, or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in First Solar you have until August 24, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to First Solar Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for First Solar Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Attorney advertising.
Prior results do not guarantee similar outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/302698

Source: Bronstein, Gewirtz & Grossman, LLC

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

HomeDividends AnalysisDividend IdeasEnergy Analysis

SummaryEnbridge Inc. offers a compelling mix of stable dividends and essential infrastructure, with a 4.87% yield and robust growth prospects.ENB’s toll-taker model insulates cash flows from commodity price swings, focusing on volume and long-term, regulated contracts.The company dominates North American oil and gas transport, moving 30% of oil and 20% of U.S. natural gas, with expanding utility and renewables exposure.I view ENB as a durable, low-volatility holding with steady, predictable growth, supported by its unmatched scale and resilient business model.I view EBBGF as icing on the cake in terms of income from this steady growth company.Looking for a helping hand in the market? Members of The Investor's Edge® get exclusive ideas and guidance to navigate any climate. Learn More » Twin Lightning Bolts

mypum/iStock via Getty Images

Lightning striking twice is not necessarily a bad thing…

Especially when it combines a superb dividend flow and a well-established, growing company in a critical business.

I own, and also own for my

26.53K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of ENB, EBBGF either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Realty Income is the best REIT to buy now given its portfolio structure and risk-adjusted return potential. O's portfolio boasts exceptional diversification, resilient occupancy, and a weighted average lease term of 8.7 years, supporting cash flow predictability. International expansion, especially in Europe and data centers, significantly expands O's TAM and provides access to differentiated growth and financing opportunities.

© Ground Picture / Shutterstock.com

Few stocks in this market have been as polarizing as Palantir (NASDAQ:PLTR | PLTR Price Prediction). Bears have called it overvalued at every turn, yet the company keeps delivering. After eight straight earnings beats and a 10-point full-year guidance raise, we are updating our view.

Our 24/7 Wall St. price target for Palantir is $163.30, implying 23.36% upside from $132.38. We rate shares a buy.

24/7 Wall St. Price Target Summary Metric Value Current Price $132.38 24/7 Wall St. Price Target $163.30 Upside 23.36% Recommendation BUY Confidence Level 90% A Sell-Off That Runs Against the Fundamentals Palantir shares are down 25.52% year to date and 14.03% over the past year, trading 12% below the 52-week high of $207.52.

This drawdown occurred against a Q1 2026 report that was extraordinary. Revenue hit $1.633 billion, up 84.7% year-over-year, U.S. commercial jumped 133%, and adjusted EPS of $0.33 beat consensus by 18.07%, the eighth consecutive beat.

Management raised full-year 2026 revenue guidance to $7.65 to $7.662 billion, a 10-point acceleration in growth. Free cash flow of $924.63 million now exceeds the entire Q1 2025 revenue line. Rackspace expanded its AI infrastructure partnership with Palantir in mid-July, validating the enterprise AIP narrative.

Why Bulls See a Breakout Above $200 The bull case rests on demand outrunning supply. CEO Alex Karp said on the Q1 call, “Our biggest problem currently in the U.S. is that we just cannot meet demand.” Net dollar retention hit 150%, remaining deal value reached $11.8 billion, and the Rule of 40 score landed at 145%.

Wall Street consensus target sits at $183.12 with 20 Buy ratings against 2 Sells. Our bull scenario models $203.91 within a year if AIP adoption compounds.

The Risks Worth Watching The bear case begins with valuation. Palantir trades at a 148x trailing P/E and 90x forward earnings, multiples that leave no room for a stumble. Director Alexander Moore sold over $2.1 million in stock on July 15, 2026, with a planned sale of 48,000 additional shares. Competitors like BigBear.ai position model-agnostic platforms as a flexibility alternative.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Palantir didn't make the cut. Grab the names FREE today.

Stock-based compensation of $201.6 million in Q1 dilutes shareholders. Our bear scenario points to $143.03. Most insider selling is via Rule 10b5-1 plans, and SBC is a legitimate cost of retaining elite engineering talent core to the moat.

How Palantir Compares to NVIDIA and AMD Karp compared Palantir’s Rule of 40 to NVIDIA (NASDAQ:NVDA) and elite AI infrastructure peers. NVIDIA trades at a P/E of 33, making Palantir’s 150 multiple look extreme. But NVIDIA is a hardware play with cyclical risk, while Palantir sells recurring software.

Advanced Micro Devices (NASDAQ:AMD) is a closer valuation comp for growth-stage AI names, sitting at a P/E of 188. Against AMD, Palantir looks reasonable given its 46% GAAP operating margin. Against that peer field, our $163.30 target looks measured.

Palantir Price Prediction 2026-2030 Our 24/7 Wall St. price target of $163.30 with 90% confidence reflects a company delivering results few skeptics predicted. The bull thesis rests on U.S. commercial AI adoption sustaining triple-digit growth into 2027. The bear thesis centers on multiple compression overwhelming earnings growth. On balance, accelerating guidance and the 145 Rule of 40 tip toward buy.

Here is where our model projects Palantir could trade, assuming current growth trajectories hold.

Year 24/7 Wall St. Price Target 2026 $150 2027 $163 2028 $193 2029 $219 2030 $247 These projections assume Palantir executes on AIP commercialization and government expansion. Significant upside could come from Maven scaling, while a broader AI valuation reset remains the primary downside risk.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Palantir didn't make the cut. Grab the names FREE today.

Contact [email protected] for any questions or corrections.

Key Takeaways AI chip stocks corrected on valuation fears, but AI demand remains intact. Strong Micron and NVIDIA earnings support the long-term AI investment case. Some specific semiconductor ETFs could offer attractive dip-buying opportunities. A sharp selloff in semiconductor stocks last week has rattled markets globally, raising questions about whether the AI-fueled rally had become overextended.

Investors across Asia, Europe and the United States pulled back from AI-linked and momentum stocks that have driven market gains for much of the year.

The Philadelphia SE Semiconductor Index fell 1.6% on Friday and tumbled about 10% for the week, marking its sharpest weekly decline in more than a year, per Reuters, as quoted on Yahoo Finance. The index is now down more than 20% from its late-June record high, placing it in bear market territory, though it remains up more than 60% year to date.

Profit-Taking and Valuation Concerns Market participants attributed much of the weakness to profit-taking following a massive rally. Chuck Carlson, chief executive of Horizon Investment Services, suggested that the decline was driven more by portfolio repositioning than by deteriorating business fundamentals, per the same Reuters source.

Fresh AI Developments Fuel Investor AnxietySeveral developments intensified concerns over AI spending during the month.

Chinese AI startup Moonshot unveiled what it described as the world's largest open-weight AI model, renewing investor scrutiny over whether U.S. technology companies will generate adequate returns on their enormous AI investments.

Separately, a Bloomberg report indicated that Alphabet's Google is running months behind schedule in launching its flagship Gemini 3.5 Pro AI model, adding to worries about the pace of AI innovation.

Global Technology Stocks Come Under PressureThe semiconductor selloff coincided with weakness across global equity markets.

South Korea's KOSPI briefly entered bear market territory last, while Japan's Nikkei slipped into correction territory. Europe's technology sector also ranked among the week's weakest performers, per the above-mentioned source.

Leveraged Semiconductor ETFs Hit HardThe pullback has been even more pronounced in leveraged semiconductor ETFs.

The Direxion Daily Semiconductor Bull 3X ETF (SOXL - Free Report) has plunged more than 50% from its late-June high. The fund slumped 22.8% last week.

Goldman Sachs indicated that several large hedge funds have recently reduced exposure to leading AI infrastructure companies after building sizable positions earlier in the year, per the above-mentioned Reuters source.

According to Walter Todd, chief investment officer at Greenwood Capital, many investors had become overly confident that AI-related stocks would continue climbing. Those who borrowed money to buy these names may now be facing margin calls as prices decline.

Investors Rotate Rather Than Exit AI: How to Trade AI Now? Despite the volatility, market participants do not appear to be abandoning AI investments altogether. Options activity also suggested bargain hunting. Several semiconductor names, including SK Hynix, Micron Technology and SanDisk, attracted bullish options trades in recent sessions.

Should You Be Selective in AI Trades?U.S.-listed shares of SK Hynix briefly traded below their offering price before recovering to finish modestly higher on Friday. So, Direxion Daily SK Hynix Bull 2X ETF (SKHL), Leverage Shares 2x Long SK Hynix Daily ETF (SKHX) and T-REX 2X Long SKHY Daily Target ETF (HYNX) could be options to play (read: Tap SK Hynix's Memory Leadership With These New Leveraged ETFs).

Note that 16 single-stock leverage products tied to Samsung Electronics and SK Hynix, including two inverse products, fetched about 7 trillion won over one month, as quoted on Seoul Economics Daily. So, who says AI trade is dead?

Micron’s (MU - Free Report) underperformance last Friday was respectable as the stock slipped only 0.5%. The company has already reported Q2 results, with earnings up 1350.1% on 345.7% higher revenues. So, MU-heavy ETFs like iShares MSCI USA Value Factor ETF (VLUE - Free Report) , Strive U.S. Semiconductor ETF (SHOC - Free Report) and Global X AI Semiconductor & Quantum ETF (CHPX - Free Report) should be in focus.

Earnings Paint the True Story of AI Companies The Q2 earnings season has started strong. Many S&P 500 companies will report over the coming weeks. Two companies — Micron and NVIDIA — are significant contributors to the Tech sector's robust growth expectations, per the Earnings Trends.

Barring the contribution from Micron and NVIDIA, Q2 earnings for the rest of the Zacks Tech sector would be up 25.3% (vs. 48.8% otherwise). Hence, although NVIDIA is down 3.7% over the past month, one can consider this a buying opportunity. VanEck Fabless Semiconductor ETF (SMHX - Free Report) and VanEck Semiconductor ETF (SMH - Free Report) are some NVDA-heavy ETFs.

Bottom LineAI mania is not over yet. What’s happening currently is a valuation correction. Despite the immense demand for memory, the Roundhill Memory ETF (DRAM - Free Report) lost 8.3% last week and more than 30% past month. Even with these selloffs, the DRAM ETF is still up about 90% this year.

So, recent corrections can be seen as healthy. Investors can take this as a buying opportunity as long as the  AI boom remains in place (read: Memory Stocks & ETF DRAM in Bear Market: Time to Buy the Dip?).

Intuitive Surgical, Inc. (ISRG - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Over the past month, shares of this company have returned -15.1%, compared to the Zacks S&P 500 composite's +0.6% change. During this period, the Zacks Medical - Instruments industry, which Intuitive Surgical falls in, has gained 3.9%. The key question now is: What could be the stock's future direction?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

Intuitive Surgical is expected to post earnings of $2.59 per share for the current quarter, representing a year-over-year change of +7.9%. Over the last 30 days, the Zacks Consensus Estimate remained unchanged.

The consensus earnings estimate of $10.45 for the current fiscal year indicates a year-over-year change of +17%. This estimate has changed +0.5% over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $11.71 indicates a change of +12.1% from what Intuitive Surgical is expected to report a year ago. Over the past month, the estimate has changed +0.3%.

With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Intuitive Surgical.

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

In the case of Intuitive Surgical, the consensus sales estimate of $2.88 billion for the current quarter points to a year-over-year change of +15%. The $11.72 billion and $13.18 billion estimates for the current and next fiscal years indicate changes of +16.5% and +12.4%, respectively.

Last Reported Results and Surprise HistoryIntuitive Surgical reported revenues of $2.89 billion in the last reported quarter, representing a year-over-year change of +18.5%. EPS of $2.8 for the same period compares with $2.19 a year ago.

Compared to the Zacks Consensus Estimate of $2.81 billion, the reported revenues represent a surprise of +3.08%. The EPS surprise was +12.9%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates three times over this period.

ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Intuitive Surgical is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Intuitive Surgical. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term.

MarketBeat Week in Review – 05/04 - 05/08AMC Entertainment NYSE: AMC reported what executives described as the strongest quarterly results in the company’s 106-year history, with record revenue, record adjusted EBITDA and sharply improved free cash flow in the second quarter of 2026.

Chairman and Chief Executive Officer Adam Aron said more than 71 million guests visited AMC and Odeon theaters worldwide during the April-to-June period, up 13.5% from a year earlier. Total revenue increased 14.2% year over year to approximately $1.6 billion, while adjusted EBITDA rose 70% to $321.4 million, surpassing $300 million in a quarter for the first time, according to the company.

Get AMC Entertainment alerts:

A Prada Payday: Is AMC Back in Style?“In AMC’s entire 106-year history, there has never been a quarter like this one,” Aron said on the company’s earnings call. He added that both revenue and adjusted EBITDA exceeded Wall Street expectations.

Free cash flow for the quarter was $190.1 million, and AMC ended June with $778 million of cash on hand, excluding restricted cash.

Box Office Strength Boosts Results 3 Dividend Aristocrats Whose Yields Can Help Combat InflationAMC executives pointed to a stronger theatrical slate as a key driver of the quarter. Aron said the domestic industry box office reached $2.99 billion in the second quarter, the highest second quarter in seven years and, based on his review of the data, the fifth-best quarter in the past 50 years.

Six films from Universal, Lionsgate, A24 and Disney each opened domestically to more than $75 million during the period, Aron said. AMC’s domestic ticket revenue rose 11.4%, ahead of the 10.7% increase in the overall domestic box office, while European attendance increased 18% year over year.

Chief Financial Officer Sean Goodman said AMC’s performance was broad-based across its global circuit. In the United States, adjusted EBITDA increased 57.5% to $285.6 million. In Europe, adjusted EBITDA increased 337% to $35.8 million. Goodman noted that international revenue and EBITDA benefited by about 2% from European currency appreciation against the U.S. dollar.

Food and beverage and merchandise sales increased 15.3% globally, while “other revenues” increased 16.1%, Aron said. Goodman added that food and beverage revenue per patron and total revenue per patron reached all-time highs in both the domestic and international businesses.

Margins Improve as Costs Remain Contained AMC’s adjusted EBITDA margin rose to 20.1% in the second quarter from 13.6% a year earlier. Goodman said roughly $200 million of incremental revenue generated $131.9 million of additional adjusted EBITDA, representing about 66% flow-through.

Aron attributed the margin expansion to rising revenue and cost controls across AMC’s theaters and corporate operations. In response to an analyst question, Aron said the company may not repeat the same level of expense containment every quarter, but management intends to remain focused on keeping costs down.

“We’re going to be maniacal in continuing to try to keep our costs down,” Aron said.

Goodman said second-quarter 2026 general and administrative expenses benefited from an approximately $5.5 million credit related to insurance recoveries.

Balance Sheet Actions Reduce Debt and Interest Expense Executives also highlighted progress on AMC’s balance sheet. Aron said the company has $1.7 billion less debt than it had at the end of 2020 and does not expect significant debt maturities before 2029.

Goodman said AMC refinanced $400 million of debt due in 2027, extending the maturity by four years. The company also eliminated approximately $155.8 million of exchangeable debt due in 2030 through conversion into equity.

AMC completed a $150 million at-the-market equity offering, raising more than $85 million of gross proceeds during the second quarter, Goodman said. The company also recently completed a $200 million registered direct equity offering with several institutional investors. Following that transaction, AMC exercised its right to redeem the remaining $125.5 million of 6.8% senior subordinated notes due in 2027, with redemption scheduled for July 24, 2026.

Goodman said the refinancing and repayment actions reduced go-forward annual cash interest expense by approximately $16 million. He added that lower leverage ratios are expected to trigger interest-rate reductions on about 75% of AMC’s debt, lowering annual interest expense by approximately $51 million.

In response to a question about leverage, Goodman said AMC ultimately would like to reach around a three-times leverage level, though he acknowledged the company is not there yet. He said leverage has improved from a double-digit level to less than 6.5 times.

Premium Formats, Loyalty Programs Remain Strategic Focus AMC executives said loyalty programs and premium formats remain central to the company’s strategy. Aron said more than 40 million U.S. households have participated in AMC Stubs, and Stubs members accounted for just over 50% of AMC’s U.S. guest count in the second quarter.

AMC’s A-List subscription program ended the quarter with more than 1.1 million members, more than double its membership five years earlier, Aron said. A-List members accounted for about 20% of AMC’s U.S. patronage in the quarter.

Goodman said AMC closed seven theaters during the quarter and added six new premium large format auditoriums and 25 new XL auditoriums. Since 2020, AMC has closed 225 locations and opened 66, reducing its global theater count by 159 locations, or about 16% of its circuit. Over the same period, the company has added 77 premium large format auditoriums and 193 XL auditoriums.

Aron said AMC and Odeon now operate about 750 premium or enhanced auditoriums globally, including IMAX, Dolby, iSENSE, PRIME, ScreenX, 4DX and XL screens. He said those auditoriums represent about 8% of AMC’s screen count but generated more than 50% of AMC’s ticket gross for “The Odyssey” over the weekend discussed on the call.

AMC expects 2026 net capital expenditures of $200 million to $235 million. Goodman said the company will remain disciplined and that future capital spending will depend on box office expectations and project-level returns.

Management Expresses Optimism for 2026 Slate Looking ahead, Aron cited the opening of Universal Pictures and Christopher Nolan’s “The Odyssey,” which he said had a media-reported $124 million domestic opening weekend. AMC also said 4.3 million guests attended AMC and Odeon theaters from Thursday to Sunday during that weekend.

Aron said upcoming releases including Sony’s “Spider-Man: Brand New Day,” Warner Bros.’ “Dune: Part Three” and Disney’s “Avengers: Doomsday” support management’s view that 2026 could be the strongest post-pandemic year yet for the domestic and global box office.

Executives said AMC’s annual free cash flow breakeven box office level is currently around $10.4 billion. Aron said the company is “within sight” of being free cash flow positive on a 12-month basis, but is not there yet.

About AMC Entertainment (NYSE:AMC)AMC Entertainment Holdings, Inc operates as a leading movie exhibition company, specializing in the presentation of theatrical motion pictures across a network of multiplex cinemas. The company's core business activities encompass ticket sales, concession and refreshment services, and the licensing of premium viewing formats. AMC offers a variety of auditorium experiences, including IMAX®, Dolby Cinema™, and Cinemark's RealD 3D systems, designed to enhance audience engagement through superior sound, visual clarity, and seating comfort.

Originally founded in 1920 with its first theatre in Kansas City, AMC has evolved into one of the largest theater chains in the world.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in AMC Entertainment Right Now?Before you consider AMC Entertainment, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMC Entertainment wasn't on the list.

While AMC Entertainment currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

The world’s biggest theater chain AMC Entertainment saw its shares surge as it posted the highest quarterly revenue in its 106-year history for the three months ended in June and just cleaned up this weekend with the massive opening of Christopher Nolan’s The Odyssey.

Revenue rose 14% from 2025 second quarter to near $1.6 billion and AMC ‘s adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) surged 70% to a record $321 million. Net cash from operations rose to $235 million from $138 million. The health of the quarter was also due in large part to the chain keeping costs in check.

“While there’s still more work to do here, this was a source of hope,” wrote analyst Drew Crumb of B. Riley Securities of the latest numbers.

The exhibitor generated $190 million in free cash flow and ended the quarter with $778 million of cash and cash equivalents.

A net loss of $11.4 million compared with $4.7. million.

U.S and Europe both showed great progress, said CEO Adam Aron, noting that the company, “has often been underestimated.”

That’s due to severe financial straits during Covid followed by a dual strike by writers and actors which hit the entire exhibition industry but was magnified in AMC’s case by its large debt load. Many in the industry and on Wall Street betting for years that a Chapter 11 filing was just around the corner.

Aron noted that during the second quarter, AMC refinanced $400 million of debt, extending maturity by four years; raised about $285 million through equity offerings; and started paring down some $282 million of debt. By the end of July, he said actions to strengthen the balance sheet since the end of 2020 will have reduced principal debt balances by circa $1.7 billion, with no currently expected debt maturities until 2029.

The box office has also cooperated as it started to regain its footing this year. This past weekend saw Universal epic The Odyssey opening to $264 million globally. Some 4.3 million people turned out to AMC and Odeon theaters Thursday to Sunday, Aron said on a call after the numbers.

Total attendance rose 13.5% in the quarter from the year earlier (up 12% domestic, 18% international. Average screen count of 9,249 was down slightly from 9,402.

Shares surged more than 20% early Monday after the earnings report. The one-time meme stock has struggled, bouncing from under a buck at its low to over $3 for its high in the last 52-weeks.

Food, beverage and merchandise sales rose 15% globally.

AMC Entertainment (AMC - Free Report) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to break-even earnings per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +1,300.00%. A quarter ago, it was expected that this movie theater operator would post a loss of $0.32 per share when it actually produced a loss of $0.36, delivering a surprise of -12.5%.

Over the last four quarters, the company has surpassed consensus EPS estimates two times.

AMC Entertainment, which belongs to the Zacks Leisure and Recreation Services industry, posted revenues of $1.6 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 5.79%. This compares to year-ago revenues of $1.4 billion. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

AMC Entertainment shares have added about 24.4% since the beginning of the year versus the S&P 500's gain of 8.9%.

What's Next for AMC Entertainment?While AMC Entertainment has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for AMC Entertainment was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is breakeven on $1.46 billion in revenues for the coming quarter and -$0.22 on $5.4 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Leisure and Recreation Services is currently in the top 39% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, Marcus (MCS - Free Report) , is yet to report results for the quarter ended June 2026. The results are expected to be released on July 30.

This operator of movie theaters, hotels and resorts is expected to post quarterly earnings of $0.35 per share in its upcoming report, which represents a year-over-year change of +52.2%. The consensus EPS estimate for the quarter has been revised 1.9% lower over the last 30 days to the current level.

Marcus' revenues are expected to be $220.91 million, up 7.2% from the year-ago quarter.

Occidental Petroleum (OXY - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Shares of this oil and gas exploration and production company have returned +5.9% over the past month versus the Zacks S&P 500 composite's +0.6% change. The Zacks Oil and Gas - Integrated - United States industry, to which Occidental belongs, has gained 2.9% over this period. Now the key question is: Where could the stock be headed in the near term?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

For the current quarter, Occidental is expected to post earnings of $1.95 per share, indicating a change of +400% from the year-ago quarter. The Zacks Consensus Estimate has changed -21.7% over the last 30 days.

The consensus earnings estimate of $5.66 for the current fiscal year indicates a year-over-year change of +156.1%. This estimate has changed -2.2% over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $3.92 indicates a change of -30.8% from what Occidental is expected to report a year ago. Over the past month, the estimate has changed -8.6%.

Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Occidental is rated Zacks Rank #3 (Hold).

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

In the case of Occidental, the consensus sales estimate of $7.18 billion for the current quarter points to a year-over-year change of +11.2%. The $24.96 billion and $23.56 billion estimates for the current and next fiscal years indicate changes of -1.9% and -5.6%, respectively.

Last Reported Results and Surprise HistoryOccidental reported revenues of $5.11 billion in the last reported quarter, representing a year-over-year change of -25.3%. EPS of $1.06 for the same period compares with $0.87 a year ago.

Compared to the Zacks Consensus Estimate of $5.5 billion, the reported revenues represent a surprise of -7.03%. The EPS surprise was +63.08%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates times over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Occidental is graded A on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Occidental. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about TSMC (TSM - Free Report) .

TSMC currently has an average brokerage recommendation (ABR) of 1.24, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 17 brokerage firms. An ABR of 1.24 approximates between Strong Buy and Buy.

Of the 17 recommendations that derive the current ABR, 14 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 82.4% and 11.8% of all recommendations.

Brokerage Recommendation Trends for TSM

Check price target & stock forecast for TSMC here>>>

While the ABR calls for buying TSMC, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.

Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations.

In other words, their interests aren't always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock's price movement.

With an impressive externally audited track record, our proprietary stock rating tool, the Zacks Rank, which classifies stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), is a reliable indicator of a stock's near-term price performance. So, validating the Zacks Rank with ABR could go a long way in making a profitable investment decision.

Zacks Rank Should Not Be Confused With ABRAlthough both Zacks Rank and ABR are displayed in a range of 1--5, they are different measures altogether.

The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.

It has been and continues to be the case that analysts employed by brokerage firms are overly optimistic with their recommendations. Because of their employers' vested interests, these analysts issue more favorable ratings than their research would support, misguiding investors far more often than helping them.

On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.

Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements.

Is TSM Worth Investing In?Looking at the earnings estimate revisions for TSMC, the Zacks Consensus Estimate for the current year has increased 3.5% over the past month to $15.83.

Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #1 (Strong Buy) for TSMC. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Therefore, the Buy-equivalent ABR for TSMC may serve as a useful guide for investors.

Analysts on Wall Street project that Thermo Fisher Scientific (TMO - Free Report) will announce quarterly earnings of $5.71 per share in its forthcoming report, representing an increase of 6.5% year over year. Revenues are projected to reach $11.68 billion, increasing 7.6% from the same quarter last year.

Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.

Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.

While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.

With that in mind, let's delve into the average projections of some Thermo Fisher metrics that are commonly tracked and projected by analysts on Wall Street.

The consensus estimate for 'Revenues- Laboratory Products and Biopharma Services' stands at $6.46 billion. The estimate indicates a change of +7.7% from the prior-year quarter.

Analysts' assessment points toward 'Revenues- Specialty Diagnostics' reaching $1.17 billion. The estimate suggests a change of +2.8% year over year.

According to the collective judgment of analysts, 'Revenues- Life Sciences Solutions' should come in at $2.74 billion. The estimate indicates a year-over-year change of +9.6%.

The consensus among analysts is that 'Revenues- Analytical Instruments' will reach $1.81 billion. The estimate indicates a year-over-year change of +4.7%.

View all Key Company Metrics for Thermo Fisher here>>>

Shares of Thermo Fisher have experienced a change of +14.6% in the past month compared to the +0.6% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), TMO is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Eli Lilly (LLY - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Over the past month, shares of this drugmaker have returned +7.3%, compared to the Zacks S&P 500 composite's +0.6% change. During this period, the Zacks Large Cap Pharmaceuticals industry, which Lilly falls in, has gained 7.8%. The key question now is: What could be the stock's future direction?

Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.

Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

Lilly is expected to post earnings of $7.47 per share for the current quarter, representing a year-over-year change of +18.4%. Over the last 30 days, the Zacks Consensus Estimate has changed -0.6%.

For the current fiscal year, the consensus earnings estimate of $34.55 points to a change of +42.7% from the prior year. Over the last 30 days, this estimate has changed -3.5%.

For the next fiscal year, the consensus earnings estimate of $45.1 indicates a change of +30.6% from what Lilly is expected to report a year ago. Over the past month, the estimate has changed +1.1%.

With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Lilly.

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.

In the case of Lilly, the consensus sales estimate of $20.26 billion for the current quarter points to a year-over-year change of +30.2%. The $85.78 billion and $98.86 billion estimates for the current and next fiscal years indicate changes of +31.6% and +15.3%, respectively.

Last Reported Results and Surprise HistoryLilly reported revenues of $19.8 billion in the last reported quarter, representing a year-over-year change of +55.5%. EPS of $8.55 for the same period compares with $3.34 a year ago.

Compared to the Zacks Consensus Estimate of $17.62 billion, the reported revenues represent a surprise of +12.37%. The EPS surprise was +21.1%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.

ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.

While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Lilly is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Lilly. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.

We know earnings results are vital, but how a company performs compared to bottom line expectations can be even more important when it comes to stock prices, especially in the near-term. This means that investors might want to take advantage of these earnings surprises.

Hunting for 'earnings whispers' or companies poised to beat their quarterly earnings estimates is a somewhat common practice. But that doesn't make it easy. One way that has been proven to work is by using the Zacks Earnings ESP tool.

The Zacks Earnings ESP, ExplainedThe Zacks Expected Surprise Prediction, or ESP, works by locking in on the most up-to-date analyst earnings revisions because they can be more accurate than estimates from weeks or even months before the actual release date. The thinking is pretty straightforward: analysts who provide earnings estimates closer to the report are likely to have more information.

Now that we understand the basic idea, let's look at how the Expected Surprise Prediction works. The ESP is calculated by comparing the Most Accurate Estimate to the Zacks Consensus Estimate, with the percentage difference between the two giving us the Zacks ESP figure.

Bringing together a positive earnings ESP alongside a Zacks Rank #3 (Hold) or better has helped stocks report a positive earnings surprise 70% of the time. Furthermore, by using these parameters, investors have seen 28.3% annual returns on average, according to our 10 year backtest.

Most stocks, about 60%, fall into the #3 (Hold) category, and they are expected to perform in-line with the broader market. Stocks with a #2 (Buy) and #1 (Strong Buy) rating, or the top 15% and top 5% of stocks, respectively, should outperform the market, with Strong Buy stocks outperforming more than any other rank.

Should You Consider Danaher?Now that we understand what the ESP is and how beneficial it can be, let's dive into a stock that currently fits the bill. Danaher (DHR - Free Report) earns a #2 (Buy) right now and its Most Accurate Estimate sits at $1.85 a share, just one day from its upcoming earnings release on July 21, 2026.

DHR has an Earnings ESP figure of +0.62%, which, as explained above, is calculated by taking the percentage difference between the $1.85 Most Accurate Estimate and the Zacks Consensus Estimate of $1.84. Danaher is one of a large database of stocks with positive ESPs. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

DHR is part of a big group of Medical stocks that boast a positive ESP, and investors may want to take a look at Agilent Technologies (A - Free Report) as well.

Agilent Technologies is a Zacks Rank #3 (Hold) stock, and is getting ready to report earnings on August 26, 2026. A's Most Accurate Estimate sits at $1.49 a share 37 days from its next earnings release.

For Agilent Technologies, the percentage difference between its Most Accurate Estimate and its Zacks Consensus Estimate of $1.48 is +1.02%.

DHR and A's positive ESP figures tell us that both stocks have a good chance at beating analyst expectations in their next earnings report.

Find Stocks to Buy or Sell Before They're ReportedUse the Zacks Earnings ESP Filter to turn up stocks with the highest probability of positively, or negatively, surprising to buy or sell before they're reported for profitable earnings season trading. Check it out here >>

Wall Street analysts forecast that Honeywell International Inc. (HON - Free Report) will report quarterly earnings of $1.80 per share in its upcoming release, pointing to a year-over-year decline of 67.3%. It is anticipated that revenues will amount to $4.98 billion, exhibiting a decrease of 51.9% compared to the year-ago quarter.

The current level reflects a downward revision of 58.8% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.

Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.

While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.

Bearing this in mind, let's now explore the average estimates of specific Honeywell International metrics that are commonly monitored and projected by Wall Street analysts.

The combined assessment of analysts suggests that 'Net Sales- Industrial Automation' will likely reach $1.45 billion. The estimate points to a change of -39% from the year-ago quarter.

Analysts expect 'Segment Profit- Industrial Automation' to come in at $249.84 million. The estimate is in contrast to the year-ago figure of $456.00 million.

The consensus estimate for 'Segment Profit- Building Automation' stands at $526.58 million. Compared to the current estimate, the company reported $479.00 million in the same quarter of the previous year.

The average prediction of analysts places 'Segment Profit- Aerospace Technologies' at $1.17 billion. Compared to the current estimate, the company reported $1.10 billion in the same quarter of the previous year.

View all Key Company Metrics for Honeywell International here>>>

Shares of Honeywell International have experienced a change of -50.9% in the past month compared to the +0.6% move of the Zacks S&P 500 composite. With a Zacks Rank #5 (Strong Sell), HON is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .